Author(s):
G. Swathi, Krishna Bhavan Jyothi Kumari, Ramya Sri S
Email(s):
swathipharmacyg@gmail.com
DOI:
10.52711/2231-5713.2023.00008 
Address:
G. Swathi1*, Krishna Bhavan Jyothi Kumari1, Ramya Sri S2
1Department of Pharmaceutics, Samskruti College of Pharmacy, Affiliated to JNTUH University, Hyderabad 501301, Telangana, India.
2Department of Pharmacy, University College of Technology, Osmania University, Hyderabad – 500 007, Telangana, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 1,
Year - 2023
ABSTRACT:
The objective of this study was to formulate floating tablets (GRDDS) of Sotalol using direct compression method to increase its bioavailability and the gastric residence time of the dosage form. The Sotalol tablets were prepared by direct compression method. The tablets were prepared by using different types of polymers i.e.; Sodium CMC, Chitosan and Psyllium Husk which act as a release retardant polymer. Sodium bi carbonate (NaHCO3) was used as a gas degenerating agent and MCC (Micro crystalline cellulose) was used as a diluent. The prepared formulation were subjected to some evaluation parameters like hardness, friability, weight variation, drug content, buoyancy property, drug release study etc. In the FT-IR study it was revealed that there is no interaction between the drug and excipients. The formulation which containing Chitosan polymer and Sodium bicarbonate shows good drug release pattern with less floating lag time and good floating duration.
The in vitro drug release pattern of Sotalol floating tablets was fitted to different kinetic models which showed the highest regression for Higuchi order kinetics. Thus, it can be concluded that the floating drug delivery system of Sotalol using the appropriate polymers in right amount may enhance the activity of the drug by prolonging the gastric residence time or reducing the floating lag time.
Cite this article:
G. Swathi, Krishna Bhavan Jyothi Kumari, Ramya Sri S. Formulation and Evaluation of Sotalol Gastrorententive Tablets. Asian Journal of Pharmacy and Technology. 2023; 13(1):41-6. doi: 10.52711/2231-5713.2023.00008
Cite(Electronic):
G. Swathi, Krishna Bhavan Jyothi Kumari, Ramya Sri S. Formulation and Evaluation of Sotalol Gastrorententive Tablets. Asian Journal of Pharmacy and Technology. 2023; 13(1):41-6. doi: 10.52711/2231-5713.2023.00008 Available on: https://ajptonline.com/AbstractView.aspx?PID=2023-13-1-8
REFERENCES:
1. Pooja Gupta, Gnanarajan, Preeti Kothiyal. Floating Drug Delivery System: A Review. International Journal of Pharma Research & Review, August 2015; 4(8):37-44.
2. Shweta Arora, Floating drug delivery systems: A review AAPS Pharm SciTech.: E372–E390, Vol-6, Issue 3, September (2005).
3. GSN Koteswara Rao, KV Ramana Murthy, Aayisha Begum, B Roja Rani, Ch Ragha Naveen, B Raj Kumar, et al. Formulation and Evaluation of Floating Drug Delivery Systems of Propranolol HCl using Modified Pulsincap Technique. International Journal of Pharma Research & Review, Sept 2014; 3(9):15-22.
4. Avaru Geetha Dutt, Ande Pratyusha, Uma Maheshwar Rao, Motor Leela Keerthi, Kalakuntla Sai Krishna, Ashok Morsu. Formulation and Evaluation of Gastro Retentive Drug Delivery System of Tizanidine Hydrochloride: A Review. International Journal of Pharma Research & Review, Oct 2014; 3(10):34-45.
5. Hirtz J. The GIT absorption of drugs in man: review of current concepts and methods of investigation. Br J Clin Pharmacol. 1985; 19:77SY83S.
6. Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site specific delivery. Int J Pharm 1996; 136:117-139.
7. Gwen.M. Jantezen, and Joseph. R. Robinson, Sustained and Controlled release drug delivery systems, Chapter-15, page 501-523.
8. Ponchel G, Irache JM. Specific and nonspecific bioadhesive particulate system for oral delivery to the gastrointestinal tract. Adv Drug Del Rev. 1998; 34:191Y219.
9. Lenaerts VM, Gurny R. Gastrointestinal TractPhysiological variables affecting the performance of oral sustained release dosage forms. In: Lenaerts V, Gurny R, eds. Bioadhesive Drug Delivery System. Boca Raton, FL: CRC Press; 1990.
10. Garg.R and Gupta.GD., Progress in controlled gastroretentive delivery systems, Trop J Pharma Res, September 2008; 7 (3): 1055-1066.
11. Jain Amit K, Hatila Umashankar. A Review On Floating Drug Delivery System. IJPSR/Vol. II/ Issue III/July-September, 2011/01-06.
12. Vantrappen GR, Peeters TL, Janssens J. The secretory component of interdigestive migratory motor complex in man. Scand J Gastroenterol. 1979;14:663-667.
13. Wilson CG, Washington N. The stomach: its role in oral drug delivery. In: Rubinstein MH, ed. Physiological Pharmacetical: Biological Barriers to Drug Absorption. Chichester, UK: Ellis Horwood; 1989:47-70.
14. Grubel P. et al, Gastric emptying of non-digestible solids in the fasted dog. J. Pharm. Sci. 1987, 76, 117 – 122.
15. Roop K. Khar, Controlled Drug Delivery, Gastroretentive system 4th edn.,; 202-203.
16. Khan F.N, Dehghan H.G., Int J Health Res 2009; 2(1): 23
17. Deshpande A.A, Shah N.H, Rhodes C.T, Malick W. Pharm Res 1997; 14: 815-819
18. Davis SS, Stockwell AF, Taylor MJ. Pharm Res 1986; 3: 208-213
19. Lehr CM. Crit Rev Ther Drug Carrier Syst 1994; 11: 119-160
20. Groning R, Heun G. Drug Dev Ind Pharm 1984; 10: 527-539
21. Klausner EA, Lavy E, Friedman M, Hoffman A. J Cont Rel 2003; 90: 143-162.
22. The American Society for Gastrointestinal Endoscopy: a history Gastrointestinal Endoscopy, Volume 37, Supplement 2, March 1991, Pages S1-S26